Author(s): Richard T, Pawlus AD, Iglsias ML, Pedrot E, WaffoTeguo P,
Abstract Share this page
Abstract Stilbenoid compounds consist of a family of resveratrol derivatives. They have demonstrated promising activities in vitro and in vivo that indicate they may be useful in the prevention of a wide range of pathologies, such as cardiovascular diseases and cancers, as well have anti-aging effects. More recently stilbenoid compounds have shown promise in the treatment and prevention of neurodegenerative disorders, such as Huntington's, Parkinson's, and Alzheimer's diseases. This paper primarily focuses on the impact of stilbenoids in Alzheimer's disease and more specifically on the inhibition of β-amyloid peptide aggregation. © 2011 New York Academy of Sciences.
This article was published in Ann N Y Acad Sci
and referenced in Biochemistry & Pharmacology: Open Access